Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 300

The DOI matches its Crossref record.

The Coronary Drug Project: Initial Findings Leading to Modifications of Its Research Protocol

·1970·JAMA

Abstract

Physicians face a difficult dilemma concerning pharmacologic therapy for hyperlipidemia in patients with a history of clinical coronary heart disease (CHD). They know that susceptibility to first episodes of premature CHD is directly related to serum levels of cholesterol, and low-density and very-low-density lipoproteins.1They are also aware that elevated serum lipids-lipoproteins frequently can be reduced long-term by available drugs. However, they lack the answers to key questions about these pharmaceutical agents: Do they prevent recurrent episodes of CHD and prolong life? What is their mechanism of action? Are they reasonably safe, in long-term usage? The paucity of scientific data on these critical questions is especially troublesome in view of other problems: Treatment of coronary disease by control hyperlipidemia makes sense only as years-long therapy— and questions about drug toxicity are especially gnawing under this circumstance. Furthermore, almost all the data proving the association between hyperlipidemia and risk of

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.1970.03180070069012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 300

Metadata

Venue
JAMA
Published
1970-11-16
Volume
214
Issue
7
Pages
1303
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4232354154
Cited by
300
References
0
FWCI
13.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Coronary Drug Project: Initial Findings Leading to Modifications of Its Research Protocol. https://app.cochat.ai/papers/10.1001/jama.1970.03180070069012
The paper
The Coronary Drug Project: Initial Findings Leading to Modifications of Its Research Protocol. (1970). JAMA. https://doi.org/10.1001/jama.1970.03180070069012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.